RAREMED ACHIEVES NATION'S HIGHEST PATIENT SATISFACTION SCORE

PITTSBURGH, June 9, 2025 /PRNewswire/ -- RareMed Solutions is proud to announce that the company continues to lead the nation in patient satisfaction, achieving a highest-ever-recorded Net Promoter Score of 100 on MMIT's nationwide Patient Satisfaction Survey for the first quarter of 2025. While the industry overall saw a decrease in patient satisfaction for the quarter, RareMed delivered a chart-topping, #1 nationwide result. RareMed remains the benchmark for specialty pharmacy services patient care and continues to outperform competitors not only in the specialty pharmacy hubs category, but across all categories in the survey, underscoring the team's commitment to care for its patients.

RareMed's exceptional patient care is evident in key performance metrics where RareMed ranked #1:

• Net Promoter Score of 100 (RareMed's highest-ever result, and the highest result possible on the survey)
  
  
• 100% of patients would be very upset if they had to change specialty pharmacies
  
  
• 100% of patients were satisfied with their Prescription Fill Time
  
  
• 100% of patients were satisfied with their Treatment Contact Frequency
  
  
• 100% of patients would recommend RareMed to a friend or family member

The below are among the many quotes of high praise shared by patients about RareMed's service performance:

• "Helpful customer service, quick deliveries, [they] always follow up with me when they say they will."
  
  
• "Prompt, courteous delivery. Treated as a valuable client."
  
  
• "[RareMed] provided me with a medication that I would be unable to get otherwise, and provides it to me easily with no gap in service."

The Q1 results from MMIT's nationwide Patient Satisfaction Survey reaffirm RareMed's dedication to serving patient populations that are often underserved. RareMed's continued high performance is a testament to the company's focus on providing the benchmark-setting care and enhancing patient satisfaction. Indeed, RareMed has delivered the highest net promoter score of any entity on the survey for more than three years, and recently won MMIT's first-ever Patient Choice Award for pharmacy hubs. RareMed Solutions actively participates in the MMIT surveys each quarter to stay attuned to patient feedback and leverage insights for continuous improvement. By prioritizing patient satisfaction and operation excellence, RareMed remains the industry leader in specialty pharmacy hubs, allowing our team to change the lives of patients with rare and complex conditions.

A major THANK YOU to Team RareMed for making the extraordinary appear ordinary, and stopping at nothing to care for patients.

About RareMed

RareMed Solutions is the nation's only concierge patient services provider, focused on complex conditions. RareMed partners with biopharma to transform the lives of patients afflicted with devastating complex conditions by accelerating access to biomedical breakthroughs. RareMed offers case management, co-pay, coupon and financial assistance programs, reimbursement support, nursing support, healthcare professional education, patient adherence & education, and non-commercial pharmacy dispensing services to all fifty states, as well as custom-developed associated support technologies, and internal hub development support from its headquarters in Pittsburgh, Pennsylvania and bases across the country.

The company has a breadth of experience developing, transitioning, and maintaining therapy-specific solutions that ensure unparalleled manufacturer & patient satisfaction across outsourced, hybrid, and insourced patient services models. RareMed's undivided complex disease focus, high caliber associates, fully dedicated teams, sophisticated proprietary technology, and unique model-ambivalent enable it to address the unique needs of complex disease patients and the partners that support them. RareMed was recognized as a 2024 top workplace in the nation by USA Today and Newsweek, and consistently sets the benchmark for patient experience according to MMIT patient satisfaction surveys, most recently earning the entity's coveted Patient Choice Award in 2025. Visit our website at www.RareMed.com.

About MMIT

For nearly two decades MMIT has been solely focused on solving the "what and why" of drug coverage and has been a trusted, go-to-market partner to pharma companies, payers and providers. We believe that patients who need lifesaving treatments shouldn't face delays because accessing drugs can be confusing. As the leading provider of market access data, analytics and insights, our expert teams of clinicians, data specialists and market researchers provide clarity and confidence so that our clients can make better decisions.

Divisions of MMIT include AIS Health, creator of the Directory of Health Plans and leading healthcare publications; Zitter Health Insights, a preeminent provider of market access insights and solutions for specialty drugs; RJ Health, the market leader in pricing and coding solutions for infusion drugs covered under the medical benefit; and The Dedham Group, a U.S. market access oncology and specialty therapeutics consultancy offering research, data analytics and strategy formulation services to the life sciences industry.

About Net Promoter Score

The primary component of the MMIT Patient Satisfaction Survey is the Net Promoter Score (NPS). NPS is calculated by first asking patients how likely they would be to recommend a pharmacy to a friend or family member on a scale of 0-10. The percentage of patients that rate the pharmacy a 0-6, known as detractors, is subtracted from the percentage of patients that rate the pharmacy a 9 or 10, known as promoters, to create a score that ranges from –100 to 100. NPS is used by consumer facing companies to gauge consumer and brand loyalty.

SOURCE RareMed Solutions